Today 8 Companies Raised Over $169.1 Million.
Patient21, PharmEnable, Infinite Uptime, HaiVE, Sunhat, FLOWX.AI, JOTELULU, and Swiftsure Innovations announced funding rounds.
Interested in human due diligence services for your investment firm? Visit our website to learn more and connect with us today!
Deal #1: German Digital Health Startup Patient21 Scores $108M Funding for Expansion.
About:
Patient21, a German healthcare firm, champions the crucial doctor-patient relationship and advocates for seamless cross-specialty collaboration. They are determined to modernize the healthcare sector which often lags behind in digitization, relying on outdated processes. Using data and their professional network, Patient21 aims to provide personalized treatment and comprehensive health insights to their clients.
Funding Round Info:
Securing $108 million in a Series C round led by Israeli VC firm Pitango, the four-year-old startup is poised for growth. Other investors include Target Global, Piton Capital, PICO Venture Partners, Bertelsmann Investments, and Artian Investments. Unlike its American counterpart, Carbon Health, Patient21 uniquely merges a digital platform with physical clinics rather than offering remote healthcare. The startup has created its proprietary patient management software, directing clients to its 50+ clinics across Germany. Predominantly focused on dentistry, the firm also provides services in gynecology and general practice.
Deal #2: PharmEnable Secures $7.5M Funding Led by MP Healthcare for Advanced Drug Development.
About:
PharmEnable leverages its unique platform to create targeted therapies with the aim of replicating the specificity of biologics but with enhanced efficacy, absorption, and distribution. The company combines AI with cutting-edge medicinal chemistry to unlock difficult biological targets and design novel drug molecules. The goal is to develop highly effective treatments with fewer side effects for high-need diseases.
Funding Round Info:
Securing $7.5M in pre-Series A financing led by MP Healthcare, the venture arm of Mitsubishi Tanabe Pharma Group, PharmEnable is set to advance its drug discovery portfolio. The funding round also included contributions from existing investors like Cambridge Enterprise, University of Cambridge Enterprise Fund VIII, and others. The company's focus is on chemical novelty, diversity, and 3-dimensionality. The funding will be used to expand its portfolio of projects targeting cancer and neurological diseases. The board of directors welcomes Dr Jeffrey Moore and Dr Keith Blundy, both carrying significant biotech and pharmaceutical industry experience.
Deal #3: Tiger Global Fuels $18.8M Funding Round for Indian IoT Firm, Infinite Uptime.
About:
Infinite Uptime, an industrial IoT firm, focuses on predictive maintenance automation for industrial machines, initially targeting the manufacturing sector. The firm offers a comprehensive solution that includes hardware, cloud analytics, and control software to monitor equipment, diagnose issues, and facilitate intelligent decision-making.
Funding Round Info:
In its recent Series B3 funding round, the Indian startup bagged an extra $18.85 million, led by Tiger Global. Other existing investors like Mayfield, GSR Ventures, VenturEast, and THK also participated. The funds will be utilized to strengthen the firm's global market presence and expand its value delivery capabilities.
Deal #4: AI Startup HaiVE.Tech Secures $1M in Pre-Seed Funding Round.
About:
HaiVE uses advanced Natural Language Processing and Generative AI to offer businesses fine-tuned virtual AI teams. These teams provide optimal customer experiences in areas like pre-sales, on-boarding, and product/service support. HaiVE.Tech was founded in 2023 by Deepika Loganathan and Aravinth Ramesh with the aim to help companies adopt AI while still providing complete control and IP rights of the intelligence and data generated instead of using famous 3rd party AI services.
Funding Round Info:
HaiVE.Tech has garnered $1 million in a pre-seed funding round led by IppoPay's Founder and CEO, Mohan K. The startup plans to use the funds to bolster its operations by enhancing its engineering and marketing teams to cater to the growing demand for AI services across diverse sectors.
Deal #5: Cologne's Sunhat Bags €2M Seed Funding to Boost Supply Chain Sustainability.
About:
Sunhat, a Cologne-based startup, offers an automation tool combining software engineering and sustainability expertise to assist supply chain businesses in meeting their sustainability objectives. The tool streamlines the handling of sustainability questionnaires and ESG ratings for suppliers.
Funding Round Info:
Sunhat secured a seed funding of two million euros with notable early-stage investors like Capnamic Ventures and xdeck ventures. WEPA Ventures also participated, alongside several business angels from the tech, compliance, and sustainability sectors. The fund will be channeled towards enhancing their software solution for enterprise customers.
Deal #6: FlowX.ai Secures $35M Series A for AI-Driven Application Integration Platform.
About:
FLOWX.AI wraps and orchestrates legacy systems, making it incredibly easy for enterprises to create web and mobile front-ends for mission-critical business flows. The revolutionary AI-enabled Apeiron UX engine is able to automatically create a modern, intuitive front-end for customers and employees, helping to consolidate in a unified UI all thebusiness logic cross-systems.This enables companies with complex technology landscapes to create and launch mission-critical digital products fast, and then facilitate an easy path forward to full digital transformation.The revolutionary novel approach is 100x faster and cheaper than existing alternatives. FLOWX.AI allows delivery of enterprise-grade mobile and web digital front-ends as fast as 10 weeks, and requires much smaller engineering teams.
Funding Round Info:
FlowX.ai raised $35 million in a Series A round. The funding round, led by Dawn Capital and including PortfoLion, SeedBlink, and DayOne Capital, will fuel product development and international growth. With its headquarters in New York and an engineering team in Romania, FlowX.ai works mainly with financial enterprises, including BNP Paribas and Alpha Bank, leveraging third-party system integrators for connectivity. Their specialty lies in helping legacy institutions launch new services quickly to rival neobanks and other market newcomers. Since its inception four years ago, FlowX.ai's platform has facilitated over 30 million user interactions.
Deal #7: Jotelulu Secures €4M Series A to Propel Cloud Services for SMEs in Europe.
About:
Jotelulu is a white-label cloud services platform that enables IT companies to competitively sell cloud services to SMEs under their own brand. It provides services from multiple data centers in Madrid, with plans for quick infrastructure expansion across Europe and LATAM.
Funding Round Info:
Jotelulu, a Spain-based firm that transformed from an IT consultancy to an exclusive cloud platform for IT companies, has raised €4 million in a Series A round. The company's vision is to digitize as many small-to-medium businesses as possible in the upcoming years. The funding will be used to continue growing the partner base, expand its services, and advance its mission to boost cloud computing across Europe.
Deal #8: Swiftsure Innovations Secures $2.3M CAD in Seed Funding
About:
Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes. It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.
Funding Round Info:
Swiftsure Innovations has successfully closed a $2.3 million CAD Seed funding round. The round was led by Pelorus VC, Sandpiper Ventures, MEDTEQ+, and other pre-seed investors.
The funding will be used to commercialize SwishKit, their innovative oral care solution for intubated patients, and to fund a bacterial reduction study following a successful first-use clinical trial, as stated by Deanne McCarthy, Swiftsure's CEO and founder.